FindTrial
Sign In

Development and application of a risk assessment tool for neutropenia in tumor patients with chemoradiotherapy: a case study of lymphoma

Development and application of a risk assessment tool for neutropenia in tumor patients with chemoradiotherapy: a case study of lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093029
Enrollment
Unknown
Registered
2024-11-27
Start date
2025-01-31
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

Trail group:NA

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed lymphoma; 2. Complete medical records;

Exclusion criteria

Exclusion criteria: 1. End-stage patients; 2. Died in hospital.

Design outcomes

Primary

MeasureTime frame
sensitivity;Specificity;ROC curve;—

Countries

China

Contacts

Public ContactTang Xiaoli

Sichuan Cancer Hospital

1585470513@qq.com+86 28 85420681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026